Link Search Menu Expand Document

“Cancer patient survival can be accurately parameterized, revealing time-dependent therapeutic effects and doubling the precision of small trials” by Deborah Plana, Geoffrey Fell, Brian M. Alexander, Adam C. Palmer, Peter K. Sorger. bioRxiv 2021.05.14.442837; doi:

“Combinatorial benefit without synergy in recent clinical trials of immune checkpoint inhibitors” by Adam C. Palmer, Benjamin Izar , Haeun Hwangbo and Peter K. Sorger. medRxiv 2020.01.31.20019604; doi: